AAAAAA
Results:
1-16
|
Results: 16
Authors:
O'Donnell, RT
DeNardo, SJ
Yuan, A
Shen, S
Richman, CM
Lara, PN
Griffith, IJ
Goldstein, DS
Kukis, DL
Martinez, GS
Mirick, GR
DeNardo, GL
Meyers, FJ
Citation: Rt. O'Donnell et al., Radioimmunotherapy with In-111/Y-90-2IT-BAD-m170 for metastatic prostate cancer, CLIN CANC R, 7(6), 2001, pp. 1561-1568
Authors:
DeNardo, GL
DeNardo, SJ
Kukis, DL
O'Donnell, RT
Shen, S
Mirick, GR
Meares, CF
Citation: Gl. Denardo et al., Metabolite production in patients with lymphoma after radiometal-labeled antibody administration, J NUCL MED, 42(9), 2001, pp. 1324-1333
Authors:
DeNardo, GL
DeNardo, SJ
Wessels, BW
Kukis, DL
Miyao, N
Yuan, AN
Citation: Gl. Denardo et al., I-131-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors:Loss of tumor specificity due to radiolysis, CANC BIO R, 15(6), 2000, pp. 547-560
Authors:
O'Donnell, RT
DeNardo, SJ
DeNardo, GL
Miers, L
Lamborn, KR
Kukis, DL
Meyers, FJ
Citation: Rt. O'Donnell et al., Efficacy and toxicity of radioimmunotherapy with Y-90-DOTA-Peptide-ChL6 for PC3-tumored mice, PROSTATE, 44(3), 2000, pp. 187-192
Authors:
O'Donnell, RT
Shen, S
Denardo, SJ
Wun, T
Kukis, DL
Goldstein, DS
Denardo, GL
Citation: Rt. O'Donnell et al., A phase I study of Y-90-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma, ANTICANC R, 20(5C), 2000, pp. 3647-3655
Authors:
DeNardo, GL
O'Donnell, RT
Shen, S
Kroger, LA
Yuan, AN
Meares, CF
Kukis, DL
DeNardo, SJ
Citation: Gl. Denardo et al., Radiation dosimetry for Y-90-2IT-BAD-Lym-1 extrapolated from pharmacokinetics using In-111-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma, J NUCL MED, 41(5), 2000, pp. 952-958
Authors:
Kukis, DL
DeNardo, SJ
Mills, SL
Shen, S
O'Donnell, RT
DeNardo, GL
Citation: Dl. Kukis et al., Stability of monoclonal antibodies, Lym-1 and ChL6, and 2IT-BAD-Lym-1 immunoconjugate with ultra freezer storage, CANC BIO R, 14(5), 1999, pp. 363-369
Authors:
O'Donnell, RT
Leigh, BR
Christensen, SD
Goldstein, DS
Kukis, DL
Shen, S
Yuan, A
DeNardo, DA
Kroger, LA
Denardo, GL
Citation: Rt. O'Donnell et al., Radioimmunotherapy of acquired immunodeficiency syndrome (AIDS) associatedlymphoma, CANC BIO R, 14(3), 1999, pp. 167-176
Authors:
DeNardo, GL
Kukis, DL
Shen, S
DeNardo, DA
Meares, CF
DeNardo, SJ
Citation: Gl. Denardo et al., Cu-67- versus I-131-labeled Lym-1 antibody: Comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma, CLIN CANC R, 5(3), 1999, pp. 533-541
Authors:
Richman, CM
DeNardo, SJ
O'Donnell, RT
Goldstein, DS
Shen, S
Kukis, DL
Kroger, LA
Yuan, A
Boniface, GR
Griffith, IJ
DeNardo, GL
Citation: Cm. Richman et al., Dosimetry-based therapy in metastatic breast cancer patients using Y-90 monoclonal antibody 170H.82 with autologous stem cell support and cyclosporina, CLIN CANC R, 5(10), 1999, pp. 3243S-3248S
Authors:
O'Donnell, RT
DeNardo, GL
Kukis, DL
Lamborn, KR
Shen, S
Yuan, AN
Goldstein, DS
Mirick, GR
DeNardo, SJ
Citation: Rt. O'Donnell et al., (67)Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl]-TETA Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma, CLIN CANC R, 5(10), 1999, pp. 3330S-3336S
Authors:
DeNardo, SJ
DeNardo, GL
Kukis, DL
Shen, S
Kroger, LA
DeNardo, DA
Goldstein, DS
Mirick, GR
Salako, Q
Mausner, LF
Srivastava, SC
Meares, CE
Citation: Sj. Denardo et al., Cu-67-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma, J NUCL MED, 40(2), 1999, pp. 302-310
Authors:
O'Donnell, RT
DeNardo, GL
Kukis, DL
Lamborn, KR
Shen, S
Yuan, AN
Goldstein, DS
Carr, CE
Mirick, GR
DeNardo, SJ
Citation: Rt. O'Donnell et al., A clinical trial of radioimmunotherapy with Cu-67-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma, J NUCL MED, 40(12), 1999, pp. 2014-2020
Authors:
O'Donnell, RT
DeNardo, SJ
Miers, LA
Kukis, DL
Mirick, GR
Kroger, LA
DeNardo, GL
Citation: Rt. O'Donnell et al., Combined modality radioimmunotherapy with taxol and Y-90-LYM-1 for Raji lymphoma xenografts, CANC BIO R, 13(5), 1998, pp. 351-361
Authors:
Denardo, SJ
Richman, CM
Kukis, DL
Shen, S
Lamborn, KR
Miers, LA
Kroger, LA
Perez, EA
DeNardo, GL
Citation: Sj. Denardo et al., Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: Development of a clinical protocol, ANTICANC R, 18(6A), 1998, pp. 4011-4018
Authors:
Kukis, DL
DeNardo, SJ
DeNardo, GL
O'Donnell, RT
Meares, CF
Citation: Dl. Kukis et al., Optimized conditions for chelation of Yttrium-90-DOTA immunoconjugates, J NUCL MED, 39(12), 1998, pp. 2105-2110
Risultati:
1-16
|